HomeLBRX • NASDAQ
add
LB Pharmaceuticals Inc
Previous close
$25.30
Day range
$25.20 - $26.19
Year range
$13.36 - $27.55
Market cap
744.97M USD
Avg Volume
268.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.97M | 134.16% |
Net income | -11.47M | -126.23% |
Net profit margin | — | — |
Earnings per share | -0.45 | — |
EBITDA | -12.88M | -136.03% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 295.21M | 954.37% |
Total assets | 312.93M | 833.18% |
Total liabilities | 11.62M | -15.94% |
Total equity | 301.31M | — |
Shares outstanding | 28.67M | — |
Price to book | 2.12 | — |
Return on assets | -10.23% | — |
Return on capital | -10.48% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -11.47M | -126.23% |
Cash from operations | -18.10M | -219.56% |
Cash from investing | -40.00K | -100.30% |
Cash from financing | -1.17M | — |
Net change in cash | -19.31M | -345.31% |
Free cash flow | -16.22M | — |
About
Founded
2015
Website
Employees
27
